 Janelle Noel-MacDonnell
Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DiGeorge Syndrome | 2 | 2022 | 5 | 1.120 |
Why?
| | Hypocalcemia | 1 | 2022 | 4 | 0.900 |
Why?
| | Humans | 35 | 2023 | 6797 | 0.810 |
Why?
| | Bronchopulmonary Dysplasia | 4 | 2022 | 41 | 0.730 |
Why?
| | Retrospective Studies | 17 | 2023 | 1332 | 0.720 |
Why?
| | Tracheostomy | 4 | 2022 | 11 | 0.650 |
Why?
| | Sequence Analysis, RNA | 1 | 2018 | 24 | 0.640 |
Why?
| | Models, Genetic | 1 | 2018 | 33 | 0.640 |
Why?
| | Female | 16 | 2023 | 3599 | 0.470 |
Why?
| | Substance-Related Disorders | 2 | 2023 | 32 | 0.420 |
Why?
| | Lung Diseases | 2 | 2021 | 26 | 0.390 |
Why?
| | Child | 11 | 2023 | 3257 | 0.380 |
Why?
| | Genetic Testing | 2 | 2021 | 81 | 0.360 |
Why?
| | Lung | 2 | 2020 | 74 | 0.350 |
Why?
| | Infant, Newborn | 9 | 2022 | 828 | 0.350 |
Why?
| | Risk Factors | 8 | 2023 | 470 | 0.340 |
Why?
| | Infant | 9 | 2023 | 1449 | 0.320 |
Why?
| | Male | 12 | 2021 | 3328 | 0.300 |
Why?
| | Contraception | 2 | 2023 | 33 | 0.280 |
Why?
| | Respiration, Artificial | 2 | 2022 | 17 | 0.250 |
Why?
| | Cluster Analysis | 3 | 2019 | 45 | 0.250 |
Why?
| | Gastric Bypass | 1 | 2023 | 8 | 0.240 |
Why?
| | Pregnancy in Adolescence | 1 | 2023 | 5 | 0.230 |
Why?
| | Heart Ventricles | 1 | 2023 | 52 | 0.230 |
Why?
| | Intrauterine Devices | 1 | 2023 | 4 | 0.230 |
Why?
| | Electronic Health Records | 2 | 2021 | 62 | 0.230 |
Why?
| | Health Education | 1 | 2023 | 39 | 0.220 |
Why?
| | Lymphopenia | 1 | 2022 | 1 | 0.220 |
Why?
| | Risk Assessment | 2 | 2020 | 137 | 0.220 |
Why?
| | Calcium | 1 | 2022 | 36 | 0.220 |
Why?
| | Gastrostomy | 1 | 2023 | 68 | 0.220 |
Why?
| | Transcriptome | 2 | 2022 | 52 | 0.220 |
Why?
| | Cardiac Surgical Procedures | 1 | 2022 | 30 | 0.220 |
Why?
| | Rhinitis | 1 | 2022 | 3 | 0.220 |
Why?
| | Sinusitis | 1 | 2022 | 5 | 0.220 |
Why?
| | Mediastinal Neoplasms | 1 | 2021 | 5 | 0.210 |
Why?
| | Anesthesia | 1 | 2021 | 4 | 0.210 |
Why?
| | Muscle Hypotonia | 1 | 2021 | 7 | 0.210 |
Why?
| | Nose Diseases | 1 | 2021 | 1 | 0.200 |
Why?
| | Velopharyngeal Insufficiency | 1 | 2021 | 1 | 0.200 |
Why?
| | Voice Disorders | 1 | 2021 | 1 | 0.200 |
Why?
| | Cleft Palate | 1 | 2021 | 8 | 0.200 |
Why?
| | Kidney Transplantation | 1 | 2022 | 114 | 0.200 |
Why?
| | Genetic Association Studies | 1 | 2021 | 54 | 0.200 |
Why?
| | Atrial Flutter | 1 | 2021 | 1 | 0.200 |
Why?
| | Enterocolitis, Necrotizing | 1 | 2022 | 71 | 0.200 |
Why?
| | Leukemia | 1 | 2021 | 17 | 0.200 |
Why?
| | Neurotoxins | 1 | 2021 | 3 | 0.200 |
Why?
| | Ear, Inner | 1 | 2020 | 1 | 0.200 |
Why?
| | Labyrinth Diseases | 1 | 2020 | 1 | 0.200 |
Why?
| | Temporal Bone | 1 | 2020 | 1 | 0.200 |
Why?
| | Anatomic Variation | 1 | 2020 | 1 | 0.200 |
Why?
| | Hearing Loss | 1 | 2020 | 4 | 0.200 |
Why?
| | Hypoplastic Left Heart Syndrome | 1 | 2021 | 22 | 0.200 |
Why?
| | Diverticulum | 1 | 2020 | 4 | 0.200 |
Why?
| | Botulinum Toxins | 1 | 2021 | 7 | 0.200 |
Why?
| | Environment Design | 1 | 2021 | 16 | 0.200 |
Why?
| | Adult | 5 | 2023 | 1259 | 0.190 |
Why?
| | Child Development | 1 | 2020 | 42 | 0.190 |
Why?
| | Enterocolitis | 1 | 2021 | 37 | 0.190 |
Why?
| | Neonatal Nursing | 1 | 2020 | 2 | 0.190 |
Why?
| | Chorioamnionitis | 1 | 2020 | 4 | 0.190 |
Why?
| | Genetic Predisposition to Disease | 1 | 2021 | 224 | 0.190 |
Why?
| | Hirschsprung Disease | 1 | 2021 | 59 | 0.180 |
Why?
| | Language Development | 1 | 2019 | 3 | 0.180 |
Why?
| | Conscious Sedation | 1 | 2019 | 1 | 0.180 |
Why?
| | Simulation Training | 1 | 2019 | 1 | 0.180 |
Why?
| | Waiting Lists | 1 | 2019 | 12 | 0.180 |
Why?
| | Professional-Family Relations | 1 | 2019 | 8 | 0.180 |
Why?
| | Neonatology | 1 | 2019 | 6 | 0.180 |
Why?
| | Echocardiography | 1 | 2020 | 78 | 0.180 |
Why?
| | Cognition | 1 | 2019 | 31 | 0.180 |
Why?
| | Education, Medical, Graduate | 1 | 2019 | 11 | 0.180 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2019 | 3 | 0.180 |
Why?
| | Appointments and Schedules | 1 | 2019 | 13 | 0.180 |
Why?
| | Toll-Like Receptor 4 | 1 | 2019 | 13 | 0.180 |
Why?
| | Practice Guidelines as Topic | 1 | 2020 | 97 | 0.180 |
Why?
| | Postoperative Complications | 1 | 2021 | 194 | 0.180 |
Why?
| | Crowdsourcing | 1 | 2019 | 1 | 0.170 |
Why?
| | Communication | 1 | 2019 | 54 | 0.170 |
Why?
| | Heart Defects, Congenital | 1 | 2020 | 82 | 0.170 |
Why?
| | Normal Distribution | 1 | 2018 | 4 | 0.170 |
Why?
| | Models, Statistical | 1 | 2018 | 34 | 0.170 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2019 | 81 | 0.170 |
Why?
| | Magnetic Resonance Imaging | 1 | 2019 | 116 | 0.170 |
Why?
| | Lipoprotein(a) | 1 | 2018 | 1 | 0.170 |
Why?
| | Cholesterol, HDL | 1 | 2018 | 9 | 0.170 |
Why?
| | Likelihood Functions | 1 | 2018 | 6 | 0.160 |
Why?
| | Treatment Outcome | 4 | 2023 | 667 | 0.160 |
Why?
| | Parents | 1 | 2019 | 152 | 0.160 |
Why?
| | Health Behavior | 1 | 2018 | 72 | 0.160 |
Why?
| | Child, Preschool | 5 | 2020 | 1503 | 0.160 |
Why?
| | Cardiovascular Diseases | 1 | 2018 | 51 | 0.160 |
Why?
| | Patient Readmission | 1 | 2018 | 68 | 0.160 |
Why?
| | Patient Compliance | 1 | 2018 | 71 | 0.160 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 244 | 0.150 |
Why?
| | Respiratory Tract Infections | 1 | 2018 | 75 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2018 | 139 | 0.150 |
Why?
| | Myositis, Inclusion Body | 1 | 2016 | 1 | 0.140 |
Why?
| | Homeostasis | 1 | 2016 | 8 | 0.140 |
Why?
| | Proteins | 1 | 2016 | 22 | 0.140 |
Why?
| | Pediatric Obesity | 1 | 2018 | 128 | 0.140 |
Why?
| | Infant, Premature | 3 | 2022 | 85 | 0.140 |
Why?
| | Intensive Care Units, Neonatal | 3 | 2021 | 34 | 0.130 |
Why?
| | Adolescent | 4 | 2023 | 2137 | 0.120 |
Why?
| | Pregnancy | 2 | 2023 | 271 | 0.090 |
Why?
| | Age Factors | 2 | 2020 | 215 | 0.090 |
Why?
| | Young Adult | 2 | 2023 | 665 | 0.090 |
Why?
| | Gestational Age | 2 | 2020 | 66 | 0.090 |
Why?
| | Cohort Studies | 2 | 2021 | 274 | 0.090 |
Why?
| | Patient Discharge | 2 | 2021 | 60 | 0.090 |
Why?
| | Time Factors | 2 | 2020 | 247 | 0.090 |
Why?
| | Databases, Factual | 2 | 2019 | 106 | 0.080 |
Why?
| | Mutation | 2 | 2021 | 199 | 0.080 |
Why?
| | Clinical Trials as Topic | 2 | 2019 | 44 | 0.080 |
Why?
| | Cross-Sectional Studies | 2 | 2018 | 319 | 0.070 |
Why?
| | Mice | 2 | 2019 | 312 | 0.070 |
Why?
| | Animals | 2 | 2019 | 664 | 0.070 |
Why?
| | Socioeconomic Factors | 1 | 2023 | 63 | 0.060 |
Why?
| | Fluoroscopy | 1 | 2023 | 20 | 0.060 |
Why?
| | Radiography | 1 | 2023 | 41 | 0.060 |
Why?
| | Pregnancy, Unplanned | 1 | 2023 | 9 | 0.060 |
Why?
| | Feasibility Studies | 1 | 2023 | 67 | 0.060 |
Why?
| | Patient-Centered Care | 1 | 2023 | 18 | 0.060 |
Why?
| | Contraceptive Agents | 1 | 2023 | 15 | 0.060 |
Why?
| | Program Evaluation | 1 | 2023 | 52 | 0.060 |
Why?
| | Pilot Projects | 1 | 2023 | 128 | 0.060 |
Why?
| | Retinoid X Receptors | 1 | 2022 | 3 | 0.060 |
Why?
| | Survival Rate | 1 | 2022 | 84 | 0.060 |
Why?
| | Chromosomes | 1 | 2022 | 3 | 0.060 |
Why?
| | Systems Analysis | 1 | 2022 | 2 | 0.060 |
Why?
| | T-Lymphocytes | 1 | 2022 | 32 | 0.050 |
Why?
| | Health Expenditures | 1 | 2022 | 15 | 0.050 |
Why?
| | Cost-Benefit Analysis | 1 | 2022 | 36 | 0.050 |
Why?
| | Enteral Nutrition | 1 | 2022 | 65 | 0.050 |
Why?
| | Fungi | 1 | 2022 | 20 | 0.050 |
Why?
| | Intubation, Intratracheal | 1 | 2021 | 1 | 0.050 |
Why?
| | Medication Adherence | 1 | 2022 | 59 | 0.050 |
Why?
| | Karyotyping | 1 | 2021 | 8 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 9 | 0.050 |
Why?
| | Oligonucleotide Array Sequence Analysis | 1 | 2021 | 45 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2022 | 205 | 0.050 |
Why?
| | Palate, Soft | 1 | 2021 | 1 | 0.050 |
Why?
| | Length of Stay | 1 | 2022 | 243 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2021 | 2 | 0.050 |
Why?
| | Standard of Care | 1 | 2021 | 5 | 0.050 |
Why?
| | Cities | 1 | 2021 | 10 | 0.050 |
Why?
| | Kansas | 1 | 2021 | 49 | 0.050 |
Why?
| | Audiometry | 1 | 2020 | 1 | 0.050 |
Why?
| | Recovery of Function | 1 | 2020 | 17 | 0.050 |
Why?
| | Incidence | 1 | 2021 | 132 | 0.050 |
Why?
| | Infant, Extremely Premature | 1 | 2020 | 13 | 0.050 |
Why?
| | Chronic Disease | 1 | 2021 | 104 | 0.050 |
Why?
| | Longitudinal Studies | 1 | 2021 | 126 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2021 | 100 | 0.050 |
Why?
| | Phenotype | 1 | 2021 | 244 | 0.050 |
Why?
| | Walking | 1 | 2021 | 35 | 0.050 |
Why?
| | Residence Characteristics | 1 | 2021 | 43 | 0.050 |
Why?
| | Diagnostic Errors | 1 | 2020 | 8 | 0.050 |
Why?
| | Alleles | 1 | 2021 | 199 | 0.050 |
Why?
| | Weight Gain | 1 | 2020 | 23 | 0.050 |
Why?
| | Digestive System Surgical Procedures | 1 | 2021 | 45 | 0.050 |
Why?
| | Prevalence | 1 | 2020 | 149 | 0.050 |
Why?
| | Pandemics | 1 | 2021 | 85 | 0.050 |
Why?
| | Hospitals, Pediatric | 1 | 2022 | 183 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2020 | 124 | 0.050 |
Why?
| | Genotype | 1 | 2021 | 401 | 0.050 |
Why?
| | Early Diagnosis | 1 | 2020 | 34 | 0.050 |
Why?
| | Language Development Disorders | 1 | 2019 | 3 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2019 | 13 | 0.050 |
Why?
| | Self-Assessment | 1 | 2019 | 5 | 0.050 |
Why?
| | Professional Competence | 1 | 2019 | 3 | 0.050 |
Why?
| | Attitude | 1 | 2019 | 15 | 0.050 |
Why?
| | Curriculum | 1 | 2019 | 21 | 0.040 |
Why?
| | Exercise | 1 | 2021 | 125 | 0.040 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 20 | 0.040 |
Why?
| | Family | 1 | 2019 | 27 | 0.040 |
Why?
| | Health Services Accessibility | 1 | 2019 | 34 | 0.040 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 21 | 0.040 |
Why?
| | Cytokines | 1 | 2019 | 48 | 0.040 |
Why?
| | Ireland | 1 | 2019 | 1 | 0.040 |
Why?
| | Italy | 1 | 2019 | 3 | 0.040 |
Why?
| | Organizations, Nonprofit | 1 | 2019 | 3 | 0.040 |
Why?
| | Endothelial Cells | 1 | 2019 | 24 | 0.040 |
Why?
| | Pneumonia | 1 | 2019 | 31 | 0.040 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 2019 | 3 | 0.040 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2019 | 34 | 0.040 |
Why?
| | Machine Learning | 1 | 2019 | 14 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2019 | 147 | 0.040 |
Why?
| | Signal Transduction | 1 | 2019 | 111 | 0.040 |
Why?
| | Protective Factors | 1 | 2018 | 8 | 0.040 |
Why?
| | Atherosclerosis | 1 | 2018 | 2 | 0.040 |
Why?
| | Pulse Wave Analysis | 1 | 2018 | 4 | 0.040 |
Why?
| | Positive-Pressure Respiration | 1 | 2018 | 1 | 0.040 |
Why?
| | Carotid Intima-Media Thickness | 1 | 2018 | 6 | 0.040 |
Why?
| | Infant, Very Low Birth Weight | 1 | 2018 | 10 | 0.040 |
Why?
| | Oxygen | 1 | 2018 | 17 | 0.040 |
Why?
| | Self Report | 1 | 2018 | 43 | 0.040 |
Why?
| | Dyslipidemias | 1 | 2018 | 14 | 0.040 |
Why?
| | Algorithms | 1 | 2019 | 106 | 0.040 |
Why?
| | Logistic Models | 1 | 2018 | 93 | 0.040 |
Why?
| | Primary Health Care | 1 | 2018 | 44 | 0.040 |
Why?
| | Missouri | 1 | 2018 | 78 | 0.040 |
Why?
| | Surveys and Questionnaires | 1 | 2019 | 297 | 0.040 |
Why?
| | Hypertension | 1 | 2018 | 62 | 0.040 |
Why?
| | United States | 1 | 2020 | 656 | 0.040 |
Why?
| | Hydroxylamines | 1 | 2016 | 1 | 0.040 |
Why?
| | Myoblasts | 1 | 2016 | 2 | 0.040 |
Why?
| | Muscle Contraction | 1 | 2016 | 3 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2016 | 2 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2016 | 2 | 0.040 |
Why?
| | Muscle Strength | 1 | 2016 | 3 | 0.040 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 3 | 0.040 |
Why?
| | Inflammation Mediators | 1 | 2016 | 8 | 0.040 |
Why?
| | HSP70 Heat-Shock Proteins | 1 | 2016 | 4 | 0.040 |
Why?
| | Cell Survival | 1 | 2016 | 19 | 0.040 |
Why?
| | Cell Cycle Proteins | 1 | 2016 | 15 | 0.040 |
Why?
| | Cells, Cultured | 1 | 2016 | 76 | 0.040 |
Why?
| | Rats | 1 | 2016 | 155 | 0.030 |
Why?
|
|
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|